当前位置:首页 - 行情中心 - 致尚科技(301486) - 财务分析 - 利润表

致尚科技

(301486)

  

流通市值:17.21亿  总市值:68.84亿
流通股本:3217.03万   总股本:1.29亿

利润表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、营业总收入174,462,476.91501,954,837.58371,171,792.54250,219,589.19
营业收入174,462,476.91501,954,837.58371,171,792.54250,219,589.19
二、营业总成本144,446,907.54433,941,679.88314,702,708.55207,752,894.89
营业成本107,742,223.01328,403,801.9241,079,530.7164,658,687.2
税金及附加648,858.442,431,663.491,543,4951,132,177.61
销售费用7,210,053.8912,265,832.638,892,137.955,036,458.86
管理费用21,181,728.1859,196,346.0439,828,838.6623,349,061.73
研发费用12,032,985.5934,997,193.4723,485,541.6513,344,882.89
财务费用-4,368,941.57-3,353,157.65-126,835.41231,626.6
其中:利息费用553,846.968,404,860.238,090,494.486,133,798.62
其中:利息收入4,557,266.5410,669,916.294,449,639.291,247,534.5
加:公允价值变动收益106,783.111,202,177.43-3,290,991.67-2,412,330
加:投资收益3,497,419.7910,801,393.054,592,019.881,634,161.34
资产处置收益--13,835.65-36,912.69-36,912.69
资产减值损失(新)-535,493.61-3,638,605.55-2,462,361.65-1,685,794.78
信用减值损失(新)-1,352,495.142,994,512.442,707,296.522,448,483.75
其他收益2,165,070.731,999,882.335,344,713.664,661,093.96
营业利润平衡项目0000
四、营业利润33,896,854.2581,358,681.7563,322,848.0447,075,395.88
加:营业外收入5,631.674,000,467.97257.17155.03
减:营业外支出284,219.9315,817.3219,572.6710,076.4
利润总额平衡项目0000
五、利润总额33,618,266.0285,043,332.4263,103,532.5447,065,474.51
减:所得税费用2,935,193.359,518,216.26,871,144.155,826,930.46
六、净利润30,683,072.6775,525,116.2256,232,388.3941,238,544.05
持续经营净利润30,683,072.6775,525,116.2256,232,388.3941,238,544.05
归属于母公司股东的净利润14,331,494.7873,007,427.6456,875,40442,244,493.14
少数股东损益16,351,577.892,517,688.58-643,015.61-1,005,949.09
(一)基本每股收益0.110.650.440.44
(二)稀释每股收益0.110.650.440.44
八、其他综合收益432,046.71-355,832.12-63,350.28871,944.41
归属于母公司股东的其他综合收益432,046.71-355,832.12-63,350.28871,944.41
九、综合收益总额31,115,119.3875,169,284.156,169,038.1142,110,488.46
归属于母公司股东的综合收益总额14,763,541.4972,651,595.5256,812,053.7243,116,437.55
归属于少数股东的综合收益总额16,351,577.892,517,688.58-643,015.61-1,005,949.09
公告日期2024-04-242024-04-242023-10-252023-08-29
审计意见(境内)标准无保留意见
TOP↑